Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia-Reference-Cited by-同舟云学术

Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia

Published:2016-04 Issue: Volume:43 Page:13-17
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Fraison Jean-Baptiste,Mekinian Arsène,Grignano Eric,Kahn Jean-Emmanuel,Arlet Jean-Benoit,Decaux Olivier,Denis Guillaume,Buchdahl Anne-Laure,Omouri Mohamed,Maigne Gwenola,Aouba Achille,Leon Nathalie,Berthier Sabine,Liozon Eric,Park Sophie,Gardin Claude,Lortholary Olivier,Rossignol Julien,Fenaux Pierre,Fain Olivier,Braun Thorsten

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference20 articles.

1. Myelodysplastic syndromes (MDS) and autoimmune disorders (AD): cause or consequence?;Braun;Best Pract. Res. Clin. Haematol.,2013

2. Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases;Mekinian;Medicine (Baltimore),2014

3. Rheumatologic manifestations in myelodysplastic syndrome;Albert;J. Clin. Rheumatol.,2012

4. Neutrophilic dermatoses as systemic diseases;Prat;Clin. Dermatol.,2014

5. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol.,2009

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between myeloid disorders and adult onset-inflammatory syndromes, successful treatment with JAK-inhibitors: Case series and literature review;Leukemia Research;2024-11

2. A clinical phenotype of VEXAS syndrome with pleural effusion, infiltrates, and systemic inflammation in a 76-year-old patient: a case report;Journal of Medical Case Reports;2024-08-24

3. Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia;Leukemia & Lymphoma;2024-07-14

4. Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets;Frontiers in Hematology;2024-07-12

5. VEXAS syndrome;International Journal of Hematology;2024-05-31